Universal to all faith traditions is the call to safeguard our personal health and the health of others as a moral obligation. ICCR’s voice in the national discourse on domestic health care begins with this moral mandate. Adequate health care and the right to security during sickness is guaranteed under Article 25 of the UN Universal Declaration on Human Rights, however these rights are regularly violated and, for those in our nation least able to afford it, access to affordable health care often remains out of reach. As people of faith, we are called to address the injustices of the current health care system; as investors and professionals working in the field, we are called to address its inefficiencies.
Featured ICCR Initiatives
Pharmaceutical Equity Expectations. In early 2022, ICCR members released a set of 11 Pharmaceutical Equity Expectations which provide a roadmap for companies committed to equity, justice, and safeguarding the human right to health.
Equitable Access to COVID-19 Products. In an effort to curb the spread of COVID-19, governments made large investments in global pharma companies to spur the development of breakthrough vaccines and medicine. These same pharma companies have been accused of profiteering amidst a global vaccine shortage. ICCR members work to ensure that any medical breakthroughs derived from the public’s contribution will be priced in an accessible way that allows communities of all income levels to benefit equally.
The Medicines Patent Pool. ICCR encourages pharma companies to share patents for their life-saving HIV drug formulations through the Medicines Patent Pool as a way to make them more affordable and available where they are needed most.
Check out our 2022 #AskTheCEO YouTube Playlist:
Health: An Untapped Asset - How investors can strengthen returns by improving health outcomes. A new report from ShareAction that examines the role of investors in driving positive health outcomes..
COVID-19 Vaccine Market Dashboard. An interactive tool from Unicef for partners, manufacturers, and countries to follow the developments of the COVID-19 vaccine market with up-to-date information.